The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...
(HealthDay News) — The US Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at ...
The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday ...
More than 1 in 3 parents reported that their child has dealt with dental problems linked to a lack of routine oral hygiene, ...
We recently published an article titled Jim Cramer Discusses These 18 Stocks & President Trump’s $500 Billion AI Plan. In ...
A recent study suggested that more than 15 million U.S. adults — roughly 1 in 17 — have been diagnosed with ADHD. The ...
The TV personality, 44, was seen enjoying a train ride with the Michelin-starred chef, who posted on Instagram that they were ...